Aimei Health Terminates Business Combination with United Hydrogen After July 7, 2026 Deadline
AFJK•Aimei Health Technology terminated its June 19, 2024 business combination agreement with United Hydrogen Group on July 7, 2026 after the extended outside date expired, as amended June 6, 2025. The deal’s collapse frees Aimei from merger obligations and redirects management to pursue new strategic transactions.
1. History of Business Combination Agreement
Aimei entered into a merger agreement with United Hydrogen Group on June 19, 2024 and amended key terms on June 6, 2025 to extend closing deadlines and refine transaction responsibilities, aiming to integrate hydrogen production capabilities.
2. Termination Effective July 7, 2026
Aimei delivered a termination notice under Section 9.1(b) on July 7, 2026 after the deal failed to close by the outside date, instantly releasing both parties from any further obligations under the agreement.
3. Strategic Outlook Post-Termination
CEO Xie Junheng emphasized confidence in securing a compelling transaction in the future, with the board refocusing on identifying and executing alternative strategic or M&A opportunities to drive shareholder value.
